Seasonal Affective Disorder: Causes, Symptoms, and Effective Treatments

As the seasons change, many people notice shifts in mood and energy. For some, these changes become more severe, causing significant disruptions in daily life. This condition is called Seasonal Affective Disorder (SAD). Seasonal Affective Disorder is a mood disorder that follows a predictable seasonal pattern.

Most people with SAD begin to show symptoms in late fall or early winter, which then improve during the sunnier spring and summer months. In rare cases, the pattern is opposite, with symptoms starting in spring or summer. SAD is classified under major depressive disorder (MDD) or bipolar disorder, depending on the type of symptoms. It is more than just a mild seasonal slump; it can interfere with functioning at work, school, and in relationships if not treated.

How Common Is SAD and Who Is Affected?

SAD affects about 5% of adults in the United States, with symptoms lasting roughly 40% of the year. A milder form of the condition, sometimes called "subsyndromal SAD," impacts another 10 to 20 percent of the population.

Prevalence rises in areas farther from the equator, where seasonal light changes are more significant. For example, people living in northern regions such as Alaska, Canada, and parts of Scandinavia are at higher risk than those in tropical climates.

Women are disproportionately affected—about four times more likely to be diagnosed with SAD than men. The typical age of onset is between 18 and 30, though children and adolescents can also develop symptoms. Other risk factors include a personal or family history of depression or bipolar disorder, low vitamin D levels, and preexisting mood or anxiety disorders.

Recognizing the Symptoms

The symptoms of SAD closely resemble those of major depressive disorder but follow a seasonal pattern. People with winter-onset SAD often report persistent low mood, a noticeable drop in energy, and a loss of interest or pleasure in activities they usually enjoy. Cognitive symptoms such as difficulty concentrating, indecisiveness, and a sense of hopelessness are also common.

Physical symptoms often include increased sleep (hypersomnia), low energy despite sufficient rest, and appetite changes—especially cravings for carbohydrates, which can result in weight gain. Many individuals also report social withdrawal, sometimes described as "hibernating." In more severe cases, suicidal thoughts may occur. For those with the less common summer-pattern SAD, symptoms may include insomnia, decreased appetite, restlessness, and anxiety.

What Causes SAD?

Although the exact biological mechanisms behind SAD are still being researched, several key factors are thought to play a role. One of the main theories involves the disruption of circadian rhythms—our internal biological clocks that control sleep, mood, and hormones. The decrease in natural sunlight during winter months can disrupt these rhythms, which then impacts mood and energy levels.

Another contributing factor is the decrease in serotonin levels that often occurs with less sunlight exposure. Serotonin is a neurotransmitter involved in regulating mood, and lower levels have been linked to depression.

Additionally, changes in melatonin production, which regulate sleep cycles, may also be a factor. Melatonin is usually produced in higher amounts during the darker months, possibly increasing sleepiness and affecting mood. Vitamin D deficiency, more common during winter due to less sun exposure, may also impact serotonin activity and worsen symptoms.

Diagnosing Seasonal Affective Disorder

A diagnosis of SAD relies on a clinical evaluation that includes a thorough assessment of symptoms, their seasonal timing, and how long they last. To meet the diagnostic criteria, a person must have depressive episodes in the same season for at least two consecutive years, with complete remission during other seasons. It’s crucial for clinicians to rule out other medical conditions, such as hypothyroidism or anemia, that can imitate depressive symptoms.

Treatment Options

SAD is a treatable condition, and several approaches—often used together—have proven to be effective. These include light therapy, psychotherapy, medications, emerging treatments like ketamine, and lifestyle changes modifications.

Light Therapy

Light therapy, or phototherapy, is a primary treatment for winter-pattern SAD. It involves sitting in front of a specially designed light box that emits bright light (usually 10,000 lux) for 20 to 45 minutes each morning. This mimics natural sunlight and helps regulate circadian rhythms and neurotransmitter activity. Studies suggest that light therapy improves symptoms in 60 to 80 percent of people with SAD and often leads to noticeable improvement within one to two weeks. It is important to use these devices under medical supervision, especially for individuals with bipolar disorder, since improper use can trigger manic episodes.

Cognitive Behavioral Therapy 

Cognitive Behavioral Therapy specifically designed for SAD, often called CBT-SAD, has proven to be very effective. This structured talk therapy helps individuals identify negative thought patterns and replace them with healthier ways of thinking.

A key part of CBT-SAD is behavioral activation—encouraging people to participate in meaningful and enjoyable activities even when their mood is low. Research shows that CBT-SAD not only reduces symptoms in the short term but may also provide longer-lasting protection against seasonal recurrences compared to light therapy alone.

Antidepressant Medications

Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to treat SAD. Medications like sertraline, fluoxetine, and escitalopram can help balance serotonin levels and alleviate depressive symptoms.

Another option, bupropion XL, is specifically approved by the FDA for the prevention of SAD when started in the early fall before symptoms begin.

While effective, these medications may cause side effects such as nausea, insomnia, or sexual dysfunction and are generally prescribed for seasonal use under the guidance of a physician.

Ketamine and Esketamine

In recent years, ketamine has become a promising treatment for various forms of treatment-resistant depression, including SAD. Administered intravenously in clinical settings, ketamine can deliver rapid antidepressant effects, sometimes within hours.

Esketamine, a related compound available as a nasal spray under the brand name Spravato, is FDA-approved for treatment-resistant depression. Both ketamine and esketamine are typically used when traditional treatments have failed and are given in a highly controlled setting due to risks like dissociation and elevated blood pressure. While not first-line therapies, they offer a valuable option for patients who do not respond to more conventional approaches.

Supplementation and Nutritional Support

Vitamin D is perhaps the most researched supplement in the context of SAD. Since low levels are common during the winter months, correcting a deficiency with supplementation may alleviate depressive symptoms. Doses typically range from 1,000 to 4,000 IU per day, but levels should ideally be tested before supplementation.

Omega-3 fatty acids, found in fish oil, have also shown potential for improving mood, likely due to their anti-inflammatory and neuroprotective properties.

Melatonin supplements may help regulate sleep patterns, but should be used cautiously and preferably under medical supervision.

Behavioral and Lifestyle Tools

In addition to clinical treatments, lifestyle changes are important in managing SAD. Regular exposure to natural light, even on cloudy days, can help stabilize mood. Spending time outdoors during daylight—especially in the morning—can make a noticeable difference.

Physical activity is also vital; aerobic exercises like walking, jogging, or swimming have consistently been shown to lessen depression symptoms. Keeping a regular sleep schedule, staying socially connected, and participating in enjoyable activities can all help boost mood and energy during the darker months.

Conclusion

Seasonal Affective Disorder is a significant mental health condition that impacts millions of people each year, especially in regions with notable seasonal changes. Although the symptoms can be severe and disruptive, the condition is highly treatable through various therapies, including light therapy, cognitive behavioral techniques, medications, newer treatments like ketamine, and lifestyle changes. Recognizing the symptoms early and seeking support can prevent seasonal depression from taking hold year after year.

Disclaimer:

The content provided on this blog and website is for educational and informational purposes only and should not be considered medical advice. Newy supplements are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement, especially if you are pregnant, nursing, have a medical condition, or are taking other medications.

References:

Feifel, D. Breaking Sad: Unleashing the Breakthrough Potential of Ketamine's Rapid Antidepressant Effects. Drug Development Research, vol. 77, no. 8, 2016, pp. 489–494. doi:10.1002/ddr.21347.

Freed, Michael C. Costs and Cost-Effectiveness of Seasonal Affective Disorder Treatment: Comparing Light Therapy, Group Cognitive-Behavioral Therapy, and Their Combination. 2005. doi:10.57912/23869071.v1.

Jupe, T., et al. “Treatment of Seasonal Affective Disorder. The Efficacy of Light Therapy.” European Psychiatry, vol. 66, suppl. 1, 2023, pp. S604–S605. doi:10.1192/j.eurpsy.2023.1262.

“Mayo Clinic Staff.” Seasonal Affective Disorder (SAD): Diagnosis & Treatment. Mayo Clinic, 14 Dec. 2021, www.mayoclinic.org/diseases-conditions/seasonal-affective-disorder/diagnosis-treatment/drc-20364722.

Munir, Sadaf, Sasidhar Gunturu, and Muhammad Abbas. “Seasonal Affective Disorder.” StatPearls [Internet], StatPearls Publishing, updated 20 Apr. 2024, https://www.ncbi.nlm.nih.gov/books/NBK568745/.

Park, L. T., et al. “The Effects of Ketamine on Typical and Atypical Depressive Symptoms.” Acta Psychiatrica Scandinavica, vol. 142, no. 5, 2020, pp. 394–401. doi:10.1111/acps.13216.

Rohan, Kelly J., et al. “Randomized Trial of Cognitive-Behavioral Therapy Versus Light Therapy for Seasonal Affective Disorder: Acute Outcomes.” The American Journal of Psychiatry, vol. 172, no. 9, 2015, pp. 862–869. doi:10.1176/appi.ajp.2015.14101293.

Terman, Michael, J. S. Terman, F. M. Quitkin, and Patrick J. McGrath. “Light Therapy for Seasonal Affective Disorder: A Review of Efficacy.” Neuropsychopharmacology, vol. 2, no. 1, 1989, pp. 1–22. doi:10.1016/0893-133X(89)90002-X.